MetLife, Inc. (MET) Stock Forecast
Data as of Sep 16, 2026Financial Services · Current price $98.33 (+0.71%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 13, 2026 | Yaron Kinar | Mizuho Securities | $93.00 | -5.4% |
| Feb 10, 2026 | Thomas Gallagher | Evercore ISI | $95.00 | -3.4% |
| Jan 13, 2026 | Elyse Greenspan | Wells Fargo | $97.00 | -1.4% |
| Oct 7, 2025 | Bob Huang | Morgan Stanley | $97.00 | -1.4% |
| Sep 19, 2025 | John Barnidge | Piper Sandler | $84.00 | -14.6% |
| Sep 15, 2025 | Tracy Benguigui | Wolfe Research | $95.00 | -3.4% |
| Jul 14, 2025 | Bob Huang | Morgan Stanley | $98.00 | -0.3% |
| Apr 2, 2025 | John Barnidge | Piper Sandler | $94.00 | -4.4% |
| Oct 2, 2024 | John Barnidge | Piper Sandler | $92.00 | -6.4% |
| Sep 4, 2024 | Alex Scott | Barclays | $91.00 | -7.5% |
| Aug 1, 2024 | Joshua Shanker | Bank of America Securities | $96.00 | -2.4% |
| Jul 10, 2024 | Bob Huang | Morgan Stanley | $83.00 | -15.6% |
| May 22, 2024 | Kevin Heal | Argus Research | $80.00 | -18.6% |
| May 6, 2024 | John Barnidge | Piper Sandler | $82.00 | -16.6% |
| Mar 13, 2024 | Catherine Seifert | CFRA | $77.00 | -21.7% |
| Jan 8, 2024 | Alex Scott | Goldman Sachs | $80.00 | -18.6% |
| Sep 14, 2023 | Brett Linzey | Mizuho Securities | $145.00 | +47.5% |
| Jun 22, 2022 | Charles Lederer | Wolfe Research | $74.00 | -24.7% |
| Jan 5, 2022 | Thomas Gallagher | Evercore ISI | $75.00 | -23.7% |
| Dec 2, 2021 | Alex Scott | Goldman Sachs | $77.00 | -21.7% |
Top Analysts Covering MET
MET vs Sector & Market
| Metric | MET | Financial Services Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.08 | 2.51 | 2.42 |
| Analyst Count | 26 | 8 | 18 |
| Target Upside | +4.5% | +82.7% | +19.5% |
| P/E Ratio | 19.06 | -4.79 | 38.67 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $77.58B | $79.57B | $81.97B | 7 |
| 2027-12-31 | $80.59B | $83.19B | $85.67B | 7 |
| 2028-03-31 | $20.83B | $21.58B | $22.43B | 1 |
| 2028-06-30 | $20.98B | $21.73B | $22.59B | 1 |
| 2028-09-30 | $21.36B | $22.13B | $23.01B | 1 |
| 2028-12-31 | $21.89B | $22.67B | $23.57B | 1 |
| 2029-03-31 | $21.72B | $22.50B | $23.40B | 2 |
| 2029-06-30 | $21.95B | $22.74B | $23.64B | 2 |
| 2029-09-30 | $22.11B | $22.91B | $23.82B | 2 |
| 2029-12-31 | $23.11B | $23.94B | $24.89B | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $9.58 | $9.79 | $10.33 | 11 |
| 2027-12-31 | $10.65 | $10.93 | $11.44 | 11 |
| 2028-03-31 | $2.60 | $2.72 | $2.86 | 4 |
| 2028-06-30 | $2.91 | $3.04 | $3.20 | 4 |
| 2028-09-30 | $3.02 | $3.16 | $3.32 | 6 |
| 2028-12-31 | $3.02 | $3.16 | $3.32 | 4 |
| 2029-03-31 | $2.74 | $2.87 | $3.01 | 3 |
| 2029-06-30 | $3.27 | $3.43 | $3.61 | 3 |
| 2029-09-30 | $3.33 | $3.49 | $3.67 | 6 |
| 2029-12-31 | $3.27 | $3.42 | $3.60 | 3 |
Frequently Asked Questions
What is the analyst consensus for MET?
The consensus among 26 analysts covering MetLife, Inc. (MET) is Buy with an average price target of $101.00.
What is the highest price target for MET?
The highest price target for MET is $145.00, set by Brett Linzey at Mizuho Securities on 2023-09-14.
What is the lowest price target for MET?
The lowest price target for MET is $68.00, set by Andrew Kligerman at Credit Suisse on 2021-05-13.
How many analysts cover MET?
26 analysts have issued ratings for MetLife, Inc. in the past 12 months.
Is MET a buy or sell right now?
Based on 26 analyst ratings, MET has a consensus rating of Buy (2.08/5) with a +4.5% upside to the consensus target of $101.00.
What are the earnings estimates for MET?
Analysts estimate MET will report EPS of $9.79 for the period ending 2026-12-31, with revenue estimated at $79.57B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.